Home » BioE Gets Blood Processing System Cleared
BioE Gets Blood Processing System Cleared
The FDA issued 510(k) clearance to BioE for its PrepaCyte-CB Processing System. The system processes umbilical cord blood to obtain potentially therapeutic cells that can be transplanted in humans. The system is composed of three attached processing and storage bags containing PrepaCyte-CB separation solution, which removes roughly 99 percent of red blood cells from the final processed cord blood unit, BioE said.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May